The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, ...

SOMERSET, N.J., February 20, 2025--(BUSINESS WIRE)--Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has ...

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony, ...

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on condition of ...

Due to concerns about these chemicals’ links to cancer risks, the FDA under the Biden administration considered proposing a ban on these ingredients in certain cosmetic products such as chemical ...

In January, Galapagos partnered with another CDMO, Catalent, to use its commercial cell therapy manufacturing facility to produce GLPG5101 for clinical trials in New York, New Jersey, and nearby areas ...

FDA wants to increase its authority to compel reporting by ... The biggest direct CDMO story in 2024 was Novo Holdings’ $16.5 billion acquisition of Catalent, one of the world’s largest pure-play ...

Changes to the FDA labeling guidance in support of FALCPA include alterations to the definitions of “major” food allergens milk, egg, and tree nuts. The FDA has reduced its list of tree nuts requiring ...

NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT). Such investors are advised to contact ...